Tang Kevin

Insider·Aurinia Pharmaceuticals Inc.·AUPH·Insider since 2025·Form 4 filings: 9
Trades YTD
0
Trades (12m)
3
Net position
Current holdings
P-code buys (12m)
3open-market
Cluster
None

Transaction history · last 12 months

3 transactions
05 Aug 2025
BOUGHT
$AUPH
200,000
$11.68
P
04 Aug 2025
BOUGHT
$AUPH
100,000
$11.34
P
01 Aug 2025
BOUGHT
$AUPH
1,000,000
$10.12
P

Transaction codes: P open-market purchase · S sale · M option exercise · A grant.

Cluster context · Aurinia Pharmaceuticals Inc.

no co-insider activity · last 30 days

No active insider cluster at Aurinia Pharmaceuticals Inc. in the last 30 days. Kevin's recent transactions appear in the section above. Kevin is the only insider with a recent P-code purchase on file. A cluster requires three or more open-market buyers within the 30-day window.

Convergence · Pattern Engine ships in v1.1

30-day window
In development

Convergence participation lands with the Pattern Engine.

Once the Pattern Engine ships, this section will list every active convergence event Kevin is named in — the hedge funds and Congress members on the same name, the 30-day window, and the combined position size.

Context

Form 4 background

Form 4 filings are required within two business days of any insider transaction by an officer, director, or 10%+ shareholder. Open-market purchases (transaction code P) are the most signal-rich because they indicate the insider is paying market price with personal cash — as distinct from option exercises, scheduled sales, or compensation grants. Cluster buying — three or more insiders of the same company buying open-market shares in a 30-day window — has historically been one of the strongest positive insider-trading signals in the academic literature.

Source data: SEC EDGAR · Form 4 filings · Last refreshed 04:28 UTC.